+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Peptides in Antifungal Therapy. Cutting-Edge Innovations and Clinical Applications

  • Book

  • September 2026
  • Elsevier Science and Technology
  • ID: 6251623
Peptides in Antifungal Therapy: Cutting-Edge Innovations and Clinical Applications takes an interdisciplinary and comprehensive approach to antifungal peptides and the effective ways they can be utilized to combat fungal infections and improve antifungal therapies. The book begins with an introduction to antifungal peptides. It also discusses the natural and synthetic sources of antifungal peptides, details the molecular mechanisms by which these peptides fight fungal infections, and explores the clinical applications and deliver the therapeutic potential of antifungal peptides. This book will be a very useful resource for those engaged in the study of fungal infections and peptide-based therapeutics.

Table of Contents

1. Introduction to Antifungal Peptides
2. Mechanisms of Action of Antifungal Peptides
3. Natural Sources of Antifungal Peptides
4. Synthetic and Engineered Antifungal Peptides
5. Nanomaterial-Antimicrobial Peptide Conjugates: Cutting-Edge Theranostics for Human Healthcare
6. Metabolomic Approaches in Antifungal Peptide Research
7. Nanotechnology in Antifungal Peptide Delivery
8. Classification of Antifungal Peptides: Insights into their Structural Diversity
9. Synergistic Approaches in Antifungal Therapy
10. Exploring the Clinical Status, Applications, and Therapeutic Potential of Antifungal Peptides
11. Advancing Antifungal Strategies for Agricultural Prosperity
12. Challenges and Future Directions in Antifungal Peptide Research

Authors

Awanish Kumar Associate Professor and Head, Department of Biotechnology, National Institute of Technology Raipur, India. Dr. Awanish Kumar is an Associate Professor of the Department of Biotechnology at the National Institute of Technology, Raipur, Chhattisgarh, India. He has more than 13 years of research experience. He received his PhD in molecular parasitology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery. Vivek Kumar Singh Senior Technical Assistant, Department of Biotechnology, National Institute of Technology, Raipur, India. Dr. Vivek Kumar Singh is currently a Senior Technical Assistant in the Department of Biotechnology at the National Institute of Technology in Raipur (CG), India. He graduated with a degree n Plant Molecular Biology from Acharya Nagarjuna University and has a MSc and PhD in Biotechnology. He completed his doctoral and post-doctoral research work at the National Research Centre for Plant Biotechnology in Delhi, India. Dr. Singh's major research interests are protein engineering, antimicrobial drug resistance, and molecular cloning. He has served in national and private organizations in different academic and research capacities. He has published a number of research papers in SCI journals and continues to actively contribute to academia and research.